$Outset Medical (OM.US)$Revenue for the third quarter of $28.7 million increased 5% compared to $27.4 million in the second quarter and declined 6% from $30.4 million in the third quarter of 2023. Product revenue of $20.3 million rose 6% from $19.2 million in the second quarter and declined 14% from $23.5 million in the third quarter of 2023. Service and other revenue was $8.4 million, roughly even with $8.2 million in the second quarter and an increase of 22% compared to $6.8 milli...
$Outset Medical (OM.US)$MT Newswires· 4 mins ago Outset Medical (OM) said Monday that the US Food and Drug Administration has granted 510(k) clearance for TabloCart with prefiltration, an optional accessory to its Tablo Hemodialysis System dialysis machine. The medical technology company said it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the US.
Outset Medical Stock Forum
📊⚡️📊
Larger Image: tradingview.com...
$Outset Medical (OM.US)$
Outset Medical (OM) said Monday that the US Food and Drug Administration has granted 510(k) clearance for TabloCart with prefiltration, an optional accessory to its Tablo Hemodialysis System dialysis machine.
The medical technology company said it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the US.
No comment yet